Literature DB >> 9535057

The nonpeptide growth hormone secretagogue, MK-0677, activates hypothalamic arcuate nucleus neurons in vivo.

A R Bailey1, R G Smith, G Leng.   

Abstract

There is accumulating evidence that the hypothalamic arcuate nucleus plays an important role in mediating the effects of growth hormone secretagogues on growth hormone (GH) release from the anterior pituitary gland. One such nonpeptidyl secretagogue, MK-0677, has been shown to directly stimulate growth hormone release from isolated pituitary cells but its central actions remain to be established. Therefore, in the present study, we have employed both immunocytochemical and in vivo electrophysiological techniques to examine the effects of MK-0677 within the hypothalamic arcuate nucleus of the male rat. In conscious male rats, both central and systemic injection of MK-0677 induced fos-like immunoreactivity specifically within the arcuate nucleus indicating selective neuronal activation of neurons within this region. MK-0677 induced-activation was generally confined close to the wall of the third ventricle, whereas systemic injection of the peptide secretagogue, GHRP-6, also induced fos-like immunoreactivity in more lateral regions of the nucleus. In urethane anaesthetized rats, intravenous injection of MK-0677 increased the electrical activity of a population of antidromically identified (i.e. neuroendocrine) arcuate neurons with a similar electrophysiological profile to cells excited by GHRP-6. The activity of neuroendocrine arcuate neurons excited by MK-0677 injection could be attenuated by a subsequent systemic injection of somatostatin. However, the activity of neuroendocrine arcuate neurons unaffected by MK-0677 injection and the activity of non-neuroendocrine arcuate neurons was unaltered by somatostatin injection. Taken together, the immunocytochemical and electrophysiological results suggest that systemic and central administration of MK-0677 activates a population of neurons in the arcuate nucleus. Furthermore, the inhibitory effects of somatostatin on MK-0677-induced excitation of these neuroendocrine cells is consistent with an action of neurons involved in the regulation of GH release.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9535057     DOI: 10.1046/j.1365-2826.1998.00176.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  7 in total

1.  Deletion of ghrelin impairs neither growth nor appetite.

Authors:  Yuxiang Sun; Saira Ahmed; Roy G Smith
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

2.  Central actions of the nonpeptide growth hormone secretagogue GHS-25.

Authors:  A R Bailey; L Gilliver; G Leng; R G Smith
Journal:  Endocrine       Date:  2001-02       Impact factor: 3.633

3.  Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor.

Authors:  Yuxiang Sun; Pei Wang; Hui Zheng; Roy G Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-18       Impact factor: 11.205

4.  Ghrelin stimulation of growth hormone-releasing hormone neurons is direct in the arcuate nucleus.

Authors:  Guillaume Osterstock; Pauline Escobar; Violeta Mitutsova; Laurie-Anne Gouty-Colomer; Pierre Fontanaud; François Molino; Jean-Alain Fehrentz; Danielle Carmignac; Jean Martinez; Nathalie C Guerineau; Iain C A F Robinson; Patrice Mollard; Pierre-François Méry
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

Review 5.  Growth hormone secretagogues and hypothalamic networks.

Authors:  M T Bluet-Pajot; V Tolle; P Zizzari; C Robert; C Hammond; V Mitchell; J C Beauvillain; C Viollet; J Epelbaum; C Kordon
Journal:  Endocrine       Date:  2001-02       Impact factor: 3.925

Review 6.  From Belly to Brain: Targeting the Ghrelin Receptor in Appetite and Food Intake Regulation.

Authors:  Ken Howick; Brendan T Griffin; John F Cryan; Harriët Schellekens
Journal:  Int J Mol Sci       Date:  2017-01-27       Impact factor: 5.923

7.  MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer's Disease.

Authors:  Yu-On Jeong; Soo Jung Shin; Jun Yong Park; Bo Kyeong Ku; Ji Soo Song; Jwa-Jin Kim; Seong Gak Jeon; Sang Min Lee; Minho Moon
Journal:  Int J Mol Sci       Date:  2018-06-18       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.